1st Quarter - Report

OGR for AMGEN USA INC

Firm
OGR
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R.1956, The Patient Protection and Innovative Biologic Medicines Act. Medicare Coverage and Reimbursement Issues.

LobbyistCovered position, as disclosed
DEAN AGUILLEN Advr, Pelosi; Dir Intgvt Aff, Labor; LA, Sandlin

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 1956 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.